Current Awardees

2022 Gill Transformative Investigator Award recipients

After a two-year wait to return to an in-person Symposium, The Linda and Jack Gill Center for Biomolecular Science is extremely excited for September 14, 2022, to present the following five scientists with the Transformative Investigator Award for their impressive contributions to neuroscience research performed on Cannabis. 

Francisco Guimaraes, Ph.D.

School of Medicine of Ribeirao Preto-University of Sao Paulo

Research Summary: Interested in investigating the role of atypical neurotransmitters (nitric oxide and endocannabinoids) in anxiety and mood control and the effects of cannabidiol, a non-psychotomimetic component on Cannabis sativa, in neuropsychiatric disorders

Additional information on Dr. Guimaraes's research
Dr. Matt Hill, Ph.D., of the University of Calgary

Matthew N. Hill, Ph.D.

Hotchkiss Brain Institute at University of Calgary

Research Summary: Interested in determining the role of the endocannabinoid system in the effects of stress on a) neuroendocrine function; b) emotional behavior; c) energy balance and metabolism; d) neuroinflammation and neurodegeneration. This is achieved through a systems approach incorporating a range of neuroscientific techniques ranging from cellular/biochemical to behavioral.

Additional information on Dr. Hill's research
Yasmin Hurd, Ph.D. of the Addiction Institute at the Icahn School of Medicine at Mount Sinai

Yasmin Hurd, Ph.D.

Addiction Institute, Icahn School of Medicine at Mount Sinai

Research Summary:  Investigating the neurobiology underlying addiction disorders and related psychiatric illnesses. A translational approach is used to examine molecular and neurochemical events in the human brain and comparable animal models in order to ascertain neurobiological correlates of behavior.

Additional information on Dr. Hurd's research
Miriam Melis, Ph.D. of the University of Cagliari (Italy)

Miriam Melis, Ph.D.

University of Cagliari (Italy)

Research Summary: Interested in understanding neurobiological underpinnings (e.g., adaptations of both mesocorticolimbic dopamine pathway and endocannabinoid system) of resilience and susceptibility to neuropsychiatric disorders (e.g., substance use disorder, antisocial behavior, anxiety, and depression).

Additional information on Dr. Melis's research
Elizabeth A. Thiele, M.D., Ph.D. of Massachusetts General Hospital / Harvard Medical School

Elizabeth A. Thiele, M.D., Ph.D.

Massachusetts General Hospital / Harvard Medical School

Research Summary: Interests include the role of diet in epilepsy treatment, genotype-phenotype correlation in TSC, the role of epilepsy surgery in management of intractable epilepsy, outcomes following infantile spasms, and neuropsychological profiles in relationship to tuber number and location in TSC.

Additional information on Dr. Thiele's research

2022 Gill Symposium & Awards

Please register now and plan to join us on Wednesday, September 14, 2022, for the 2022 Gill Symposium and Awards.

If you have any questions, please contact us!